- McKesson (NYSE:MCK) upgraded to Overweight from Equalweight at Morgan Stanley.
- Shire (NASDAQ:SHPG) upgraded to Buy from Neutral at BofA.
- Forest Labs (NYSE:FRX) upgraded to Market Perform from Underperform at BMO. Price target hiked to $33 from $27.
- Citi initiates Mylan (NASDAQ:MYL) at Neutral with a price target of $42.
- Citi starts Teva (NYSE:TEVA) at Buy with a $47 price target.
- Citi starts Actavis (NASDAQ:ACT) at Buy with a $172 price target.
Healthcare upgrades and new coverage for Friday
Recommended For You
About MCK Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| MCK | - | - |
| McKesson Corporation | ||